Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness

C. Wyatt, Robyn Lucas, C. Hurst, M.G. Kimlin

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

© 2015 Wyatt et al. Background: Epidemiological evidence shows that people with thicker, or higher stage, melanomas have lower vitamin D status compared to those with thinner tumours. Evidence from experimental studies is inconsistent, but some suggest that administration of vitamin D metabolites can decrease tumour aggressiveness. Objectives: Determine the relationship between vitamin D status at diagnosis and melanoma thickness (as an indicator of prognosis), in a subtropical setting with high melanoma incidence. Methods: We recruited 100 melanoma patients in Brisbane, Australia within days of their diagnosis. Data on factors previously associated with melanoma risk or prognosis were collected by questionnaire and physical examination. Serum for 25-hydroxyvitamin D3 [25(OH)D] levels was collected prior to wider excision biopsy; histological indicators of prognosis were obtained from pathology reports. We used multivariable logistic regression models to analyse the association between Breslow thickness (≥0.75 mm compared to
Original languageEnglish
Pages (from-to)1-13
JournalPLoS One
Volume10
Issue number5
DOIs
Publication statusPublished - 2015

Fingerprint

vitamin D deficiency
Vitamin D Deficiency
melanoma
Vitamin D
Melanoma
vitamin D
Tumors
prognosis
Calcifediol
Biopsy
Pathology
Metabolites
Logistic Models
Logistics
25-hydroxycholecalciferol
neoplasms
excision
clinical examination
Physical Examination
aggression

Cite this

Wyatt, C. ; Lucas, Robyn ; Hurst, C. ; Kimlin, M.G. / Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness. In: PLoS One. 2015 ; Vol. 10, No. 5. pp. 1-13.
@article{7abc13af66f74a579f1f6765b48fca26,
title = "Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness",
abstract = "{\circledC} 2015 Wyatt et al. Background: Epidemiological evidence shows that people with thicker, or higher stage, melanomas have lower vitamin D status compared to those with thinner tumours. Evidence from experimental studies is inconsistent, but some suggest that administration of vitamin D metabolites can decrease tumour aggressiveness. Objectives: Determine the relationship between vitamin D status at diagnosis and melanoma thickness (as an indicator of prognosis), in a subtropical setting with high melanoma incidence. Methods: We recruited 100 melanoma patients in Brisbane, Australia within days of their diagnosis. Data on factors previously associated with melanoma risk or prognosis were collected by questionnaire and physical examination. Serum for 25-hydroxyvitamin D3 [25(OH)D] levels was collected prior to wider excision biopsy; histological indicators of prognosis were obtained from pathology reports. We used multivariable logistic regression models to analyse the association between Breslow thickness (≥0.75 mm compared to",
author = "C. Wyatt and Robyn Lucas and C. Hurst and M.G. Kimlin",
year = "2015",
doi = "10.1371/journal.pone.0126394",
language = "English",
volume = "10",
pages = "1--13",
journal = "P L o S One",
issn = "1932-6203",
publisher = "Public Library of Science (PLoS)",
number = "5",

}

Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness. / Wyatt, C.; Lucas, Robyn; Hurst, C.; Kimlin, M.G.

In: PLoS One, Vol. 10, No. 5, 2015, p. 1-13.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness

AU - Wyatt, C.

AU - Lucas, Robyn

AU - Hurst, C.

AU - Kimlin, M.G.

PY - 2015

Y1 - 2015

N2 - © 2015 Wyatt et al. Background: Epidemiological evidence shows that people with thicker, or higher stage, melanomas have lower vitamin D status compared to those with thinner tumours. Evidence from experimental studies is inconsistent, but some suggest that administration of vitamin D metabolites can decrease tumour aggressiveness. Objectives: Determine the relationship between vitamin D status at diagnosis and melanoma thickness (as an indicator of prognosis), in a subtropical setting with high melanoma incidence. Methods: We recruited 100 melanoma patients in Brisbane, Australia within days of their diagnosis. Data on factors previously associated with melanoma risk or prognosis were collected by questionnaire and physical examination. Serum for 25-hydroxyvitamin D3 [25(OH)D] levels was collected prior to wider excision biopsy; histological indicators of prognosis were obtained from pathology reports. We used multivariable logistic regression models to analyse the association between Breslow thickness (≥0.75 mm compared to

AB - © 2015 Wyatt et al. Background: Epidemiological evidence shows that people with thicker, or higher stage, melanomas have lower vitamin D status compared to those with thinner tumours. Evidence from experimental studies is inconsistent, but some suggest that administration of vitamin D metabolites can decrease tumour aggressiveness. Objectives: Determine the relationship between vitamin D status at diagnosis and melanoma thickness (as an indicator of prognosis), in a subtropical setting with high melanoma incidence. Methods: We recruited 100 melanoma patients in Brisbane, Australia within days of their diagnosis. Data on factors previously associated with melanoma risk or prognosis were collected by questionnaire and physical examination. Serum for 25-hydroxyvitamin D3 [25(OH)D] levels was collected prior to wider excision biopsy; histological indicators of prognosis were obtained from pathology reports. We used multivariable logistic regression models to analyse the association between Breslow thickness (≥0.75 mm compared to

U2 - 10.1371/journal.pone.0126394

DO - 10.1371/journal.pone.0126394

M3 - Article

VL - 10

SP - 1

EP - 13

JO - P L o S One

JF - P L o S One

SN - 1932-6203

IS - 5

ER -